Department of Pharmacology

January 29, 2024

Expanded space boosts cutting-edge research in infectious diseases and immunology

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

By Leigh MacMillan
January 18, 2024

Beloved VUMC colleague and acclaimed scientist David Robertson mourned

David Robertson, MD, a beloved leader and mentor, and a pioneer in the clinical research of blood pressure disorders at Vanderbilt University Medical Center, died Jan. 12 at his home in Nashville. He was 76.

By Bill Snyder and Nancy Humphrey
January 16, 2024

‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

By Leigh MacMillan
November 14, 2023

Future of AI in medicine is bright, but rigorous validation needed

Artificial intelligence has the potential to transform the practice of medicine but, like any other new tool or method, it needs to be rigorously validated before it is widely applied, cautions Vanderbilt’s Dan Roden, MD.

By Bill Snyder
September 15, 2023

Four named Master Innovators at Vanderbilt

Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.

By Sarah Sommer
August 17, 2023

Grant aids drug discovery for autism, schizophrenia

Federal grant to help Vanderbilt researchers will pave the way for potential treatments for schizophrenia and autism spectrum disorder

By Paul Govern
June 29, 2023

Study identifies key regulator of melanoma development

Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity.
By Tom Wilemon
June 5, 2023

Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD

Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79.
By Bill Snyder
May 18, 2023

A critical skin enzyme

Detailed studies of the enzymatic properties of PNPLA1 support the requirement for this protein in skin barrier formation.
By Leigh MacMillan
April 20, 2023

Pharmacology research symposium set for April 28

Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died last year.
By Bill Snyder
January 12, 2023

Roden honored for his leadership in precision medicine

Vanderbilt's Dan Roden, MD, will receive the PMWC 2023 Pioneer Award Jan. 27 during this year’s Precision Medicine World Conference.
By Bill Snyder
December 19, 2022

Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples

BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples.
By Bill Snyder
October 17, 2022

Three Vanderbilt faculty elected to the National Academy of Medicine

Three Vanderbilt University faculty members have been elected this year to membership in the National Academy of Medicine, a prestigious, non-governmental organization that advises the nation and the world on important aspects of medical science, health care and public health.
By Bill Snyder and Kiya Gaskin
1 2 3 … 14